HIV and cardiovascular disease: contribution of HIV-infected macrophages to development of atherosclerosis
- PMID: 17411317
- PMCID: PMC1796648
- DOI: 10.1371/journal.pmed.0040043
HIV and cardiovascular disease: contribution of HIV-infected macrophages to development of atherosclerosis
Conflict of interest statement
Comment on
-
Does HIV cause cardiovascular disease?PLoS Med. 2006 Nov;3(11):e496. doi: 10.1371/journal.pmed.0030496. PLoS Med. 2006. PMID: 17132070 Free PMC article. Review.
References
-
- Carr A, Ory D. Does HIV cause cardiovascular disease? PLoS Med. 2006;3:e496. doi: 10.1371/journal.pmed.0030496. - DOI - PMC - PubMed
-
- Mujawar Z, Rose H, Morrow MP, Pushkarsky T, Dubrovsky L, et al. Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol. 2006;4:e365. doi: 10.1371/journal.pbio.0040365. - DOI - PMC - PubMed
-
- Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, et al. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1992;74:1045–1052. - PubMed
-
- van der Valk M, Kastelein JJ, Murphy RL, van Leth F, Katlama C, et al. Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile. AIDS. 2001;15:2407–2414. - PubMed
-
- Crook MA, Mir N. Abnormal lipids and the acquired immunodeficiency syndrome: Is there a problem and what should we do about it? Int J STD AIDS. 1999;10:353–356. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
